“Design and Synthesis of Novel Triazole-Isofroxadin Molecules: Docking Studies Against Inflammatory and Tuberculosis Targets”, IJC, vol. 64, no. 3, pp. 285–290, Mar. 2025, doi: 10.56042/ijc.v64i3.16320.